Clinical Trial Update: Safety, Tolerability, and Immunogenicity of a Single Dose of Merck 0657nI Staphylococcus Aureus Vaccine With or Without Merck Aluminum Adjuvant (V710-002) [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated safety, tolerability, and immunogenicity of a single dose of Merck's V710 Staphylococcus aureus vaccine, given with or without Merc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Infections

Drugs mentioned

• Merck Aluminum Adjuvant
• V710 Staphylococcus aureus vaccine

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Staphylococcal Infections | Phase 1 | Status: COMPLETED | Results posted: 2011-10-17